S&P 500   3,966.26 (-3.00%)
DOW   31,834.24 (-2.51%)
QQQ   294.64 (-3.77%)
AAPL   142.76 (-4.34%)
MSFT   257.36 (-3.55%)
FB   195.89 (-3.32%)
GOOGL   2,256.00 (-3.15%)
AMZN   2,175.79 (-5.70%)
TSLA   724.09 (-4.93%)
NVDA   172.95 (-4.85%)
BABA   88.71 (-3.57%)
NIO   16.09 (-3.25%)
AMD   97.71 (-4.65%)
CGC   5.70 (-3.23%)
MU   71.26 (-4.32%)
T   20.43 (-0.68%)
GE   75.58 (-1.07%)
F   12.96 (-4.21%)
DIS   105.31 (-3.07%)
AMC   13.21 (+2.40%)
PFE   50.44 (-1.75%)
PYPL   78.22 (-1.92%)
NFLX   181.38 (-4.82%)
S&P 500   3,966.26 (-3.00%)
DOW   31,834.24 (-2.51%)
QQQ   294.64 (-3.77%)
AAPL   142.76 (-4.34%)
MSFT   257.36 (-3.55%)
FB   195.89 (-3.32%)
GOOGL   2,256.00 (-3.15%)
AMZN   2,175.79 (-5.70%)
TSLA   724.09 (-4.93%)
NVDA   172.95 (-4.85%)
BABA   88.71 (-3.57%)
NIO   16.09 (-3.25%)
AMD   97.71 (-4.65%)
CGC   5.70 (-3.23%)
MU   71.26 (-4.32%)
T   20.43 (-0.68%)
GE   75.58 (-1.07%)
F   12.96 (-4.21%)
DIS   105.31 (-3.07%)
AMC   13.21 (+2.40%)
PFE   50.44 (-1.75%)
PYPL   78.22 (-1.92%)
NFLX   181.38 (-4.82%)
S&P 500   3,966.26 (-3.00%)
DOW   31,834.24 (-2.51%)
QQQ   294.64 (-3.77%)
AAPL   142.76 (-4.34%)
MSFT   257.36 (-3.55%)
FB   195.89 (-3.32%)
GOOGL   2,256.00 (-3.15%)
AMZN   2,175.79 (-5.70%)
TSLA   724.09 (-4.93%)
NVDA   172.95 (-4.85%)
BABA   88.71 (-3.57%)
NIO   16.09 (-3.25%)
AMD   97.71 (-4.65%)
CGC   5.70 (-3.23%)
MU   71.26 (-4.32%)
T   20.43 (-0.68%)
GE   75.58 (-1.07%)
F   12.96 (-4.21%)
DIS   105.31 (-3.07%)
AMC   13.21 (+2.40%)
PFE   50.44 (-1.75%)
PYPL   78.22 (-1.92%)
NFLX   181.38 (-4.82%)
S&P 500   3,966.26 (-3.00%)
DOW   31,834.24 (-2.51%)
QQQ   294.64 (-3.77%)
AAPL   142.76 (-4.34%)
MSFT   257.36 (-3.55%)
FB   195.89 (-3.32%)
GOOGL   2,256.00 (-3.15%)
AMZN   2,175.79 (-5.70%)
TSLA   724.09 (-4.93%)
NVDA   172.95 (-4.85%)
BABA   88.71 (-3.57%)
NIO   16.09 (-3.25%)
AMD   97.71 (-4.65%)
CGC   5.70 (-3.23%)
MU   71.26 (-4.32%)
T   20.43 (-0.68%)
GE   75.58 (-1.07%)
F   12.96 (-4.21%)
DIS   105.31 (-3.07%)
AMC   13.21 (+2.40%)
PFE   50.44 (-1.75%)
PYPL   78.22 (-1.92%)
NFLX   181.38 (-4.82%)
NASDAQ:CGEM

Cullinan Oncology News Headlines

$11.57
-0.48 (-3.98%)
(As of 05/18/2022 12:22 PM ET)
Add
Compare
Today's Range
$11.57
$12.18
50-Day Range
$7.31
$14.45
52-Week Range
$7.30
$37.66
Volume
9,285 shs
Average Volume
993,229 shs
Market Capitalization
$518.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.22
Get Cullinan Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Cullinan Oncology Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CGEM
News Sentiment

0.21

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CGEM Articles
This Week

13

1

CGEM Articles
Average Week



Cullinan Oncology (NASDAQ:CGEM) News Headlines Today

SourceHeadline
marketbeat.com logoQ2 2022 Earnings Forecast for Cullinan Oncology, Inc. Issued By SVB Leerink (NASDAQ:CGEM)
marketbeat.com - May 18 at 7:34 AM
marketbeat.com logoCullinan Oncology (NASDAQ:CGEM) Receives Buy Rating from HC Wainwright
marketbeat.com - May 17 at 12:16 PM
marketbeat.com logoCullinan Oncology (NASDAQ:CGEM) Posts Earnings Results, Beats Estimates By $0.34 EPS
marketbeat.com - May 17 at 7:16 AM
MarketBeat logoCullinan Oncology (NASDAQ:CGEM) Rating Increased to Hold at Zacks Investment Research
americanbankingnews.com - May 18 at 2:16 AM
benzinga.com logoShort Volatility Alert: Cullinan Oncology
benzinga.com - May 17 at 3:45 PM
MarketBeat logoCullinan Oncology, Inc. (NASDAQ:CGEM) Major Shareholder Vision Scs F2 Sells 35,158 Shares of Stock
americanbankingnews.com - May 17 at 4:52 AM
MarketBeat logoCullinan Oncology, Inc. (NASDAQ:CGEM) Major Shareholder Vision Scs F2 Sells 264,072 Shares of Stock
americanbankingnews.com - May 17 at 4:10 AM
investing.com logoCullinan Oncology Reports Q1 Net Loss of $12.9M
investing.com - May 16 at 10:03 AM
nasdaq.com logoNotable Thursday Option Activity: ROKU, CGEM, CPRI
nasdaq.com - May 13 at 3:40 AM
finance.yahoo.com logoCullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl
finance.yahoo.com - May 12 at 8:38 AM
finance.yahoo.com logoCompanies Like Cullinan Oncology (NASDAQ:CGEM) Are In A Position To Invest In Growth
finance.yahoo.com - May 8 at 10:13 AM
MarketBeat logoFinancial Review: ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) versus Cullinan Oncology (NASDAQ:CGEM)
americanbankingnews.com - May 3 at 1:48 AM
finance.yahoo.com logoCullinan Oncology to Present Updated Data Highlighting the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting
finance.yahoo.com - April 27 at 12:49 PM
finance.yahoo.com logoCullinan Oncology to Participate in Upcoming Virtual Healthcare Conferences
finance.yahoo.com - April 5 at 8:13 AM
finance.yahoo.com logoCullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - April 4 at 4:59 PM
finance.yahoo.com logoCullinan Oncology Lead Cancer Program Shows Confirmed ORR Of 41% In Lung Cancer Setting
finance.yahoo.com - March 29 at 6:02 PM
finance.yahoo.com logoCullinan Oncology Announces Clinical and Regulatory Update for CLN-081 in NSCLC EGFR Exon 20 Patients
finance.yahoo.com - March 28 at 6:09 PM
tmcnet.com logoCullinan Oncology to Host CLN-081 Regulatory Update
tmcnet.com - March 17 at 3:41 PM
seekingalpha.com logoCullinan Oncology GAAP EPS of -$0.74 misses by $0.30
seekingalpha.com - March 17 at 3:41 PM
finance.yahoo.com logoCullinan Oncology to Host CLN-081 Regulatory Update Webinar on March 28, 2022
finance.yahoo.com - March 17 at 3:41 PM
finance.yahoo.com logoCullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
finance.yahoo.com - March 17 at 3:41 PM
finance.yahoo.com logoCullinan Oncology to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 9 at 8:20 AM
finance.yahoo.com logoCullinan Oncology to Present Data Demonstrating Breadth and Progress of Its Immuno-Oncology Portfolio at AACR 2022
finance.yahoo.com - March 8 at 8:39 PM
finance.yahoo.com logoCullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones, M.D., MPH, MBA to Chief Medical Officer and Anne-Marie Martin Ph.D. to Board of Directors
finance.yahoo.com - February 28 at 12:22 PM
finance.yahoo.com logoInvestors in Cullinan Oncology (NASDAQ:CGEM) have unfortunately lost 66% over the last year
finance.yahoo.com - February 12 at 11:39 AM
finance.yahoo.com logoCullinan Oncology to Present at SVB Leerink’s 11th Annual Global Healthcare Conference
finance.yahoo.com - February 7 at 9:25 AM
finance.yahoo.com logoCullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment
finance.yahoo.com - January 10 at 10:19 AM
nasdaq.com logoCullinan Oncology Inc Shares Near 52-Week Low - Market Mover
nasdaq.com - January 9 at 5:48 PM
nasdaq.com logoCullinan Oncology Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - January 8 at 3:42 PM
nasdaq.com logoWe're Not Very Worried About Cullinan Oncology's (NASDAQ:CGEM) Cash Burn Rate
nasdaq.com - January 7 at 9:11 AM
nasdaq.com logoCullinan Oncology, Inc. Common Stock (CGEM)
nasdaq.com - January 6 at 10:25 AM
finance.yahoo.com logoCullinan Oncology to Present at Upcoming Virtual Investor Conferences
finance.yahoo.com - January 5 at 1:35 PM
finance.yahoo.com logoFDA Grants Breakthrough Therapy Designation for Cullinan Oncology’s CLN-081 in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
finance.yahoo.com - January 4 at 9:32 AM
finance.yahoo.com logoCullinan Oncology stock shoots higher after lung cancer treatment granted BTD by FDA
finance.yahoo.com - January 4 at 9:32 AM
finance.yahoo.com logoCullinan Oncology Posts Updated Data for CLN-081 in NSCLC EGFR Exon 20 Patients
finance.yahoo.com - December 16 at 6:14 PM
finance.yahoo.com logoCullinan Oncology Announces Updated Phase 1/2a Data for CLN-081 in NSCLC EGFR Exon 20 Patients
finance.yahoo.com - December 16 at 8:13 AM
finance.yahoo.com logoCullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients
finance.yahoo.com - December 13 at 8:30 AM
finance.yahoo.com logoCullinan Oncology to Participate in the Evercore ISI 4th Annual HealthconX Conference
finance.yahoo.com - November 22 at 12:51 PM
finance.yahoo.com logoCullinan Oncology to Participate in the Evercore ISI 4th Annual HealthconX Conference
finance.yahoo.com - November 22 at 12:51 PM
finance.yahoo.com logoCullinan Oncology, Inc. (NASDAQ:CGEM) insiders snagged a deal: Up US$35k on a US$4.3m investment
finance.yahoo.com - November 14 at 10:16 AM
finance.yahoo.com logoCullinan Oncology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 9 at 10:28 AM
finance.yahoo.com logoDo Hedge Funds Love Cullinan Oncology, Inc. (CGEM)?
finance.yahoo.com - October 29 at 1:10 PM
finance.yahoo.com logoCullinan Oncology Appoints Nadim Ahmed as Chief Executive Officer
finance.yahoo.com - October 18 at 7:19 AM
nasdaq.com logoCullinan Oncology, Inc. (NASDAQ:CGEM) insiders placed bullish bets worth US$4.3m in the last 12 months
nasdaq.com - October 9 at 11:09 AM
fool.com logoCullinan Oncology, Inc.(CGEM)
fool.com - September 20 at 12:52 AM
finance.yahoo.com logoCullinan Oncology to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 8 at 5:34 PM
finance.yahoo.com logoWe're Hopeful That Cullinan Oncology (NASDAQ:CGEM) Will Use Its Cash Wisely
finance.yahoo.com - August 16 at 7:40 AM
barrons.com logoCullinan Oncology Inc.
barrons.com - August 10 at 11:47 PM
finance.yahoo.com logoCullinan Oncology to Participate in the 41st Annual Canaccord Genuity Growth Conference
finance.yahoo.com - August 5 at 8:13 PM
realmoney.thestreet.com logoCullinan Oncology, Inc. (CGEM)
realmoney.thestreet.com - July 25 at 12:56 AM
finance.yahoo.com logoIs Cullinan Oncology, Inc. (CGEM) A Good Stock To Buy?
finance.yahoo.com - July 20 at 12:28 AM
finance.yahoo.com logoCullinan Oncology Receives FDA Clearance of Investigational New Drug (IND) Application for CLN-619, a Novel MICA/B-targeted Antibody for the Treatment of Solid Tumors
finance.yahoo.com - June 29 at 8:44 AM
finance.yahoo.com logoCullinan Gets FDA Investigational Clearance for Leukemia Drug
finance.yahoo.com - June 7 at 5:44 PM
Get Cullinan Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.